Colorectal Cancer Clinical Trial
— HEALABCOfficial title:
Healthy Eating and Active Lifestyle After Bowel Cancer - HEAL ABC Workbook: Development and Feasibility Trial
Verified date | October 2022 |
Source | University of Manchester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Trial Design: This is a feasibility randomised controlled trial. Aim: The study aims to test the Healthy Eating and Active Lifestyle After Bowel Cancer - HEAL ABC intervention and HEAL ABC resources for feasibility and will inform a future definitive randomised controlled trial (RCT). Objectives: 1. Is it practical to run HEAL ABC study as a definitive randomised controlled trial? 2. Adherence to intervention, motivations, barriers and facilitators of CRC survivors to follow HEAL ABC. Study Population: Colorectal cancer survivors who completed surgery and/or active treatment. Intervention: The intervention group will use HEAL ABC resource with supportive telephone calls every two weeks during the intervention period and once a month during the follow up period. Control: Participants follow standard care recommendations. Timing and duration: 3 months intervention with 6 months follow up period
Status | Completed |
Enrollment | 35 |
Est. completion date | September 30, 2022 |
Est. primary completion date | September 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults, age =18 - Minimum 12 weeks post-surgery and/or active treatment - Completed all active anti-cancer treatments, including surgery, radiotherapy or chemotherapy - Body mass index =20 kg/m2 and no previous unintentional weight loss =5% of body weight in the previous six months. - Identified as living an unhealthy lifestyle based on current recommendations - follow less than four of the WCRF/AICR recommendations on eligibility questionnaire - Ability to work with computer, smart phone or tablet. - Able to give informed consent. Exclusion Criteria: - Receiving treatment for malignancy. - Secondary malignancy. - Having short bowel syndrome, Crohn's disease, ulcerative colitis, diverticulitis or jejunostomy (due to requirement for a very specific diet). - Previous stroke, congested cardiac failure or oedema. - Hepatic or renal failure - Less than 12 weeks post-surgery or active treatment. - Meeting the requirements of a healthy lifestyle (follow four or more of the WCRF/AICR recommendations). - Being on any therapeutic diets, multiple food intolerances or allergies. - Unplanned weight loss of =10% in the previous 3-6 months. - Cannot read or communicate in English (due to resource constraints of this PhD study). |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Manchester University NHS Foundation Trust | Manchester | |
United Kingdom | Salford Royal NHS Foundation Trust | Manchester | Great Manchester |
United Kingdom | The University of Manchester | Manchester |
Lead Sponsor | Collaborator |
---|---|
University of Manchester |
United Kingdom,
Aubrey V, Hon Y, Shaw C, Burden S. Healthy eating interventions in adults living with and beyond colorectal cancer: a systematic review. J Hum Nutr Diet. 2019 Aug;32(4):501-511. doi: 10.1111/jhn.12651. Epub 2019 Apr 3. — View Citation
Burden S, Jones DJ, Sremanakova J, Sowerbutts AM, Lal S, Pilling M, Todd C. Dietary interventions for adult cancer survivors. Cochrane Database Syst Rev. 2019 Nov 22;2019(11). doi: 10.1002/14651858.CD011287.pub2. — View Citation
Burden S, Sremanakova J, Jones D, Todd C. Dietary interventions for cancer survivors. Proc Nutr Soc. 2019 Feb;78(1):135-145. doi: 10.1017/S0029665118002690. Epub 2018 Dec 19. — View Citation
Sremanakova J, Jones D, Cooke R, Burden S. Exploring Views of Healthcare Professionals, Researchers, and People Living with and beyond Colorectal Cancer on a Healthy-Eating and Active Lifestyle Resource. Nutrients. 2019 Oct 16;11(10). pii: E2482. doi: 10.3390/nu11102482. — View Citation
Wright SJ, Gibson D, Eden M, Lal S, Todd C, Ness A, Burden S. What are colorectal cancer survivors' preferences for dietary advice? A best-worst discrete choice experiment. J Cancer Surviv. 2017 Dec;11(6):782-790. doi: 10.1007/s11764-017-0615-2. Epub 2017 Apr 20. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adherence to intervention | Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues. Number of goals set and number of changes implemented in everyday life during the 3 months intervention. | 3 months | |
Primary | Adherence to intervention | Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues. Number of goals set and number of changes implemented in everyday life during the 6 months follow up. | 6 months | |
Primary | Recruitment rates | Cumulative recruitment against target rate each month. | 3 months | |
Primary | Recruitment rates | Cumulative recruitment against target rate each month. | 6 months | |
Primary | Retention rates | Calculated as the number of participants who completed the study divided by the number of participants randomised. | 3 months | |
Primary | Retention rates | Calculated as the number of participants who completed the study divided by the number of participants randomised. | 6 months | |
Primary | Acceptability of the intervention | This will be qualitatively assessed through in depth interviews with a subset of the trial participants. | 3 months | |
Primary | Acceptability of the intervention | This will be qualitatively assessed through in depth interviews with a subset of the trial participants. | 6 months | |
Primary | Data completion rates | Completeness of collected data will be assessed for all time points (% missing). | 3 months | |
Primary | Data completion rates | Completeness of collected data will be assessed for all time points (% missing). | 6 months | |
Secondary | Change in participants' experience, motivation, barriers and facilitators to use HEAL ABC resources and follow the intervention | Qualitatively assessed with in depth interviews. | 3 months and 6 months | |
Secondary | Change in behaviour | The health action process approach (HAPA) questionnaires, previously used in publications investigating changes in HAPA constructs in lifestyle interventions. A 5 point Likert scale will be used for each question. Minimum score is 15 and maximum score is 75. Higher score is better score. | Baseline, 3 months and 6 months | |
Secondary | Change in dietary intake | Three day dietary assessment. Participants will complete prospectively food diary during the day and enter all foods and drinks consumed into online system for dietary assessment - INTAKE24. | Baseline, 3 months and 6 months | |
Secondary | Change in BMI | Body weight [kg] and height [m] to calculate body mass index | Baseline, 3 months and 6 months | |
Secondary | Change in waist to hip ratio | waist circumference [cm] and hip circumference [cm] to calculate waist to hip ratio | Baseline, 3 months and 6 months | |
Secondary | Change in body composition (BIA) | lean mass [%] and fat mass [%] using bio-impedance machine | Baseline, 3 months and 6 months | |
Secondary | Change in body composition (CT scan) | muscle mass [cm2] and fat mass [cm2]using CT scans body composition analysis | Baseline, 3 months and 6 months | |
Secondary | Change in physical activity | Global Physical Activity Questionnaire is used to assess the metabolic equivalent (MET) based on Global Physical Activity Questionnaire Analysis Guide: https://www.who.int/ncds/surveillance/steps/resources/GPAQ_Analysis_Guide.pdf | Baseline, 3 months and 6 months | |
Secondary | Change in step count | pedometer | Baseline, 3 months and 6 months | |
Secondary | Patients' socio-demographic characteristics | age, gender, marital status, occupation, education, income, ethnicity, smoking status and number of supplements used | Baseline | |
Secondary | Contact with primary and secondary healthcare services | The Healthcare Resource Use Questionnaire - questionnaire was developed by a health economist for the EU funded project 'PreventIT' (2016-2018, grant number 689238) responding to the Horizon 2020, Personalised Health and Care call PHC-21: Advancing active and healthy aging with ICT: Early risk detection and intervention. There is no set score - questionnaire is used to estimate the costs associated with different healthcare services used. | 6 months | |
Secondary | Mortality | Patient's medical records | 6 months | |
Secondary | Morbidity | Patient's medical records | 6 months | |
Secondary | Change in Quality of life | SF-12 questionnaire - 12 questions, total score can range from 0 to 100 (sore zero indicates the lowest level of health and 100 indicates the highest level of health). | Baseline, 3 months and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |